Portal vein gas in emergency surgery
Executive Summary
Portal vein gas (PVG) is a critical radiological sign indicative of serious underlying intra-abdominal pathology, most notably bowel ischemia and mesenteric vascular accidents. While historically associated with a mortality rate reaching 75%, advancements in diagnostic imaging—specifically Computed Tomography (CT)—have identified an increasing number of cases related to benign conditions that can be managed conservatively.
Bowel ischemia remains the most prevalent cause, accounting for approximately 61.44% of reported cases. The diagnosis of the underlying etiology relies on the correlation of clinical signs with radiological findings. Management strategies are categorized by patient stability and the presence of acute abdominal features: immediate surgical intervention is mandated for patients with acute abdominal signs, while stable patients without mesenteric ischemia may be candidates for conservative treatment. Ultimately, prognosis is determined by the severity of the primary disease rather than the presence of the gas itself.
Overview of Portal Vein Gas (PVG)
Portal vein gas is not a disease in itself but a diagnostic clue suggesting a potential intra-abdominal catastrophe. It is characterized by the presence of gas within the portal venous system, often discovered during the assessment of patients presenting acutely to emergency departments.
Demographics and Presentation
Patient Profile: PVG predominantly affects elderly patients, though cases have been reported in infants and younger populations.
Gender Predilection: There is no specific predilection for males or females; both are affected equally.
Clinical Presentation: Most patients present with an acute onset of abdominal pain. However, some patients remain asymptomatic, with PVG discovered incidentally during investigations for unrelated issues.
Risk of Misdiagnosis: Elderly or unwell patients are occasionally misdiagnosed and admitted to medical wards without specific diagnostic tools, which can delay critical surgical intervention.
Aetiology and Statistical Distribution
Based on a review of 275 reported cases between 1975 and 2008, the underlying causes of PVG are diverse, ranging from vascular emergencies to iatrogenic injuries.
Primary Causes of Portal Vein Gas
Specific Clinical Conditions
Inflammatory Diseases: Necrotizing enterocolitis, Crohn’s disease, ulcerative colitis, acute appendicitis, and diverticulitis (perforated and non-perforated).
Gastrointestinal Pathologies: Gastric ulcers, hypertrophic pyloric stenosis, cystic fibrosis, and gastric wall necrosis.
Vascular Issues: Septic thrombophlebitis of the superior mesenteric vein and superior mesenteric artery syndrome.
Iatrogenic/Procedural: Endoscopic and radiological procedures, pancreaticoduodenectomy, gastric bypass (anastomotic leaks), and complications from percutaneous endoscopic gastrostomy (PEG) tube placement.
Rare/Miscellaneous: Respiratory tract infections, abdominal trauma, ingestion of caustics or hydrogen peroxide, and resuscitation procedures (CPR).
Diagnostic Modalities
The identification of PVG and its underlying cause relies on various radiological and clinical assessments.
Radiological Investigations
Computed Tomography (CT): The gold standard for diagnosis. It is superior in identifying the aetiology and ruling out bowel ischemia. On a CT scan, PVG appears as tubular areas of decreased attenuation in the liver, predominantly in the left lobe.
Ultrasound (US): Highly effective for detection, showing dot-like, streak-like, or "fruit-pulp-like" patterns. While useful for predicting outcomes, it is less effective than CT at identifying the specific underlying aetiology.
Plain Abdominal Radiology: Generally lacks specific diagnostic criteria and only detects PVG in approximately 12.5% of cases. It may show indirect signs like an oedematous bowel wall or ileus.
Magnetic Resonance Imaging (MRI): Useful for assessing the patency of the portal system and distinguishing between occlusive and non-occlusive ischemia.
Laboratory Findings
White Cell Count: Increased in more than 50% of cases.
Lactic Acidosis: Confirmed in more than 90% of patients with established bowel ischemia.
Other Indicators: Polycythemia and thrombocythemia may provide clues to the underlying cause.
Management and Clinical Categorization
The management of PVG is determined by the underlying cause and the patient’s clinical stability. Modern management emphasizes a tailored approach to reduce the rate of unnecessary laparotomies.
Management Categories
Immediate Surgical Intervention:
Criteria: Patients presenting with acute abdominal features and positive diagnostic criteria for PVG.
Action: Immediate exploration via laparoscopy or laparotomy.
Conservative Approach:
Criteria: Patients with positive radiological signs of PVG but who are hemodynamically stable, lack acute abdominal signs, and show no evidence of mesenteric ischemia.
Action: Observation and treatment of the underlying benign condition.
Intermediate/Borderline Approach:
Criteria: Patients with borderline acute abdominal features and less dense radiological signs of PVG.
Action: Use of endoscopy or diagnostic laparoscopy to identify or exclude GIT pathology before committing to more invasive surgery.
Prognostic Factors
Pathology vs. Sign: The presence and amount of gas in the portal system correlate with the severity of the pathology, but the final prognosis is dictated by the nature of the underlying disease itself.
Mortality: In cases of bowel ischemia, prompt surgical response is vital to reducing high mortality rates (historically reported as high as 86% in specific cohorts).
Advancements: Better outcomes are currently reported due to improvements in intensive care settings, diagnostic facilities, and the use of less invasive techniques like laparoscopy.
Conclusion
Portal vein gas remains a formidable diagnostic sign that necessitates urgent clinical evaluation. While it often signals a serious intra-abdominal emergency requiring surgery, it is not an absolute indication for operative intervention. Successful management depends entirely on the accurate correlation of clinical findings with high-quality imaging to distinguish between life-threatening catastrophes and benign conditions.
